Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders Health Condition 2: F30-F39- Mood [affective] disorders
Conditions
Interventions
Intervention1: Therapeutic writing intervention: Therapeutic writing intervention will be developed for the study, which will consist of modules of semi-structured worksheets with questions and probes
which will be completed by the participants over a period of 4 weeks.
Control Intervention1: NIL: NIL
Sponsors
Merlyn S
Dr Himani Kashyap
Eligibility
Inclusion criteria
Inclusion criteria: 1) Diagnosis of depression, neurotic, stress related and somatoform disorders (F 32-34, 38, F 40, 41, 43, 44, 45, 48 on ICD-10) as established through M.I.N.I. 2)With emotion regulation issues as measured by a score of 90 and above on the Difficulties in Emotion Regulation Scale. (Derived using means and standard deviation of two studies which had used DERS in common mental disorders in India) 3) Age range of 18- 50 years 4) With 7 years of education 5)Ability to read, write and speak in English or Tamil language.
Exclusion criteria
Exclusion criteria: 1) Diagnosis of schizophrenia, psychosis, Bipolar Affective Disorder, a history suggestive of major neurological illness or those with organic psychiatric disorders. 2) Clinical Diagnosis of Personality Disorder 3) Risk to self and others, suicidality as screened on M.I.N.I. 7.0.2 4)Severity of illness, scores of 6 and 7 on CGI 5) Clinical history suggestive of mental retardation and other developmental disorders including autism spectrum. 6) Substance dependence except for nicotine dependence syndrome 7) Who had undergone structured psychotherapy in the past 6 months, for more than 4 sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scores on Difficulties in Emotion Regulation Questionnaire(change in the level of difficulties in emotion regulation)Timepoint: Baseline (at 0 weeks) and post intervention (at end of 4 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| severity of functional impairmentTimepoint: Baseline (at 0 weeks) and post intervention (at end of 4 weeks);Symptom severity as measured on Clinical Global Impression-severity scale and improvement scaleTimepoint: Baseline (at 0 weeks) and post intervention (at end of 4 weeks) | — |
Countries
India
Contacts
Public ContactMerlyn S
National Institute of Mental health and Neurosciences
Outcome results
None listed